Skip to main content
Log in

Budget impact of monoclonal antibodies for metastatic colorectal cancer substantial in Brazil

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • da Silva WC, et al. The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil. Applied Health Economics and Health Policy : 28 Jan 2021. Available from: URL: http://doi.org/10.1007/s40258-020-00626-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Budget impact of monoclonal antibodies for metastatic colorectal cancer substantial in Brazil. PharmacoEcon Outcomes News 871, 4 (2021). https://doi.org/10.1007/s40274-021-7442-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7442-4

Navigation